Real-World Treatment Patterns, Adherence and Healthcare Resource Utilization for Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia Among Veterans in the United States

被引:4
|
作者
Yang, Keri [1 ]
Liu, Sizhu [1 ]
Tang, Boxiong [1 ]
Chanan-Khan, Asher [2 ]
机构
[1] BeiGene Ltd, Emeryville, CA USA
[2] Mayo Clin, Jacksonville, FL USA
关键词
D O I
10.1182/blood-2021-148716
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4079
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Chronic Lymphocytic Leukemia: Real-World Data From India
    Tejaswi, V
    Lad, Deepesh P.
    Jindal, Nishant
    Prakash, Gaurav
    Malhotra, Pankaj
    Khadwal, Alka
    Jain, Arihant
    Sreedharanunni, Sreejesh
    Sachdeva, Manupdesh Singh
    Naseem, Shano
    Varma, Neelam
    Varma, Subhash
    JCO GLOBAL ONCOLOGY, 2020, 6 : 866 - 872
  • [42] Real-world management of targeted therapies in chronic lymphocytic leukemia
    Weis, Taylor M.
    Gutierrez, Jillian
    Kabel, Charlene C.
    King, Amber C.
    Daley, Ryan J.
    Stump, Sarah E.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (06) : 1411 - 1433
  • [43] Real-World Effectiveness and Safety Outcomes of Acalabrutinib Treatment By Line of Therapy in Patients with Chronic Lymphocytic Leukemia and/or Small Lymphocytic Lymphoma
    Jacobs, Ryan W.
    Teschemaker, Anna
    Hakre, Shweta
    Tian, Hongping
    Pyrih, Nick
    Wahlstrom, Svea K.
    Cui, Lianzhou
    BLOOD, 2023, 142
  • [44] Real-World Treatment Patterns, Healthcare Resource Utilization and Associated Costs Among Patients with Chronic Myeloid Leukemia in Later Lines of Therapy
    Atallah, Ehab L.
    Maegawa, Rodrigo
    Latremouille-Viau, Dominick
    Rossi, Carmine
    Guerin, Annie
    Patwardhan, Pallavi
    BLOOD, 2020, 136
  • [45] Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
    Shadman, Mazyar
    Salkar, Monika
    Srivastava, Bhavini
    Karve, Sudeep
    Emond, Bruno
    Gogna, Priyanka
    Manceur, Ameur M.
    Lafeuille, Marie-Helene
    Rava, Andrew
    Sun, Haiyan
    Howarth, Amanda
    Tomicki, Samantha
    Agatep, Barnabie
    Jones, Barton
    Franceschini, Erin
    Saifan, Chadi
    Bacchus, Shaffee
    Roeker, Lindsey
    Stephens, Deborah M.
    LEUKEMIA & LYMPHOMA, 2024,
  • [46] HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG MEDICARE BENEFICIARIES INITIATING VENETOCLAX VS. BTKIS FOR RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: A REAL-WORLD STUDY
    Huntington, S.
    Manzoor, B. S.
    Jawaid, D.
    Puckett, J.
    Alhasani, H.
    Ravelo, A.
    Kamal-Bahl, S.
    Emechebe, N.
    Doshi, J. A.
    VALUE IN HEALTH, 2023, 26 (06) : S88 - S89
  • [47] Effectivness and Safety of Orelabrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Retrospective, Real-World Study in China
    Ding, Kaiyang
    Cheng, Yue-Xin
    Wang, Xiaoyong
    Huang, Chen
    Liang, Yang
    Li, Wei
    Ye, Jingjing
    Ji, Chunyan
    BLOOD, 2023, 142
  • [48] Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma
    Lei, Matthew M.
    Sorial, Mark N.
    Lou, Uvette
    Yu, Michelle
    Medrano, Andrea
    Ford, Josie
    Nemec, Ronald A.
    Abramson, Jeremy S.
    Soumerai, Jacob D.
    LEUKEMIA & LYMPHOMA, 2024, 65 (05) : 653 - 659
  • [49] Examining Treatment Patterns and Real-World Outcomes in Chronic Lymphocytic Leukemia Using Administrative Data in Ontario
    Seung, Soo Jin
    Hurry, Manjusha
    Hassan, Shazia
    Elnoursi, Ashlie
    Scheider, Krystin A. B.
    Wagner, Dennis
    Edwin, Jonathan J.
    Aw, Andrew T. W.
    CURRENT ONCOLOGY, 2021, 28 (06) : 4832 - 4844
  • [50] REAL-WORLD COMPARISON OF HEALTHCARE RESOURCE UTILIZATION AND COSTS BETWEEN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH FIRST-LINE IBRUTINIB OR ACALABRUTINIB
    Rogers, K. A.
    Qureshi, Z. P.
    Ding, Z.
    Emond, B.
    Gogna, P.
    Lafeuille, M. H.
    Bokun, A.
    Fradley, M.
    VALUE IN HEALTH, 2023, 26 (12) : S63 - S63